Rezpeg
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Rezpeg, covering 2026-03-31 to 2026-03-31. Get the full timeline:
Most recent: Clinical Trial Update: A Phase 2b Study to Evaluate Rezpegaldesleukin (Rezpeg) in the Treatment of Adult Patients With Moderate-to-Severe Atopic Dermatitis [Phase 2]